Organon And Henlius Complete Phase III For Denosumab

Pair’s HLX14 Partnered Biosimilar Rival To Prolia/Xgeva Meets Primary Endpoints

 
• By David Wallace
  
Clinical trial puzzle
HLX14 has met primary endpoints in a Phase III trial • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products